In November, the Patient Involvement team proudly hosted CRUK’s annual Cancer Insights Panel Social – a day dedicated to connection, reflection, and celebration of the incredible contributions made by ...

Lead and coordinate Tiverton’s Turn the Town Pink campaign, engaging the community, organising events, and raising funds for Cancer Research UK.

About the role In every corner of the UK, 400,000 participants are limbering up to join the fight against cancer. Last year, ...

Sign up today to kickstart your fundraising journey. Whatever activity you choose, take it on in a way that suits you. Sign up for your free fundraising inspiration ...

Testicular cancer is when abnormal cells in a testicle start to divide and grow in an uncontrolled way. The testicles are part of the male reproductive system. We have information on symptoms, getting ...

Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England ...

Incidence rates for chronic myeloid leukaemia are highest in people aged 90+ in the UK, with almost 5 in 100 (3%) of all new chronic myeloid leukaemia cases diagnosed in this age group (2017-2019).

Pancreatic cancer is when abnormal cells in the pancreas start to divide and grow in an uncontrolled way and forms a growth (tumour). The pancreas is a large gland that produces digestive juices and ...

Upper urinary tract urothelial cancer is a rare type of cancer of the lining of the kidney or ureter. It used to be called transitional cell cancer (TCC) of the kidney or ureter. This is because it ...

primary care to guide the management of people who present with signs and symptoms of suspected bowel cancer secondary care to support patient triage bowel cancer screening programmes to support the ...

Infection with Helicobacter pylori (H. pylori) increases the risk of some types of cancer, including stomach cancer. H. pylori causes a very small number of cancer cases in the UK. For most people, a ...

Building on the success of our sold-out 2024 inaugural event, we've expanded the conference to a three-day programme. We'll be exploring the future of data-enabled cancer research, highlighting the ...